Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Sa | Where Will Madrigal Pharmaceuticals Be in 3 Years? | 2 | The Motley Fool | ||
Mi | Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade | 4 | Investor's Business Daily | ||
Mi | Madrigal Pharmaceuticals' Options Frenzy: What You Need to Know | 3 | Benzinga.com | ||
Mo | Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals | 69 | The Motley Fool | ||
06.06. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra (resmetirom) Presented at the EASL Congress | 181 | GlobeNewswire (Europe) | Late-breaking AI-based analysis of MAESTRO-NASH biopsy data demonstrates Rezdiffra improved key fibrotic features that are predictive of progression to decompensated cirrhosisNoninvasive test data... ► Artikel lesen | |
05.06. | What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday? | 13 | Benzinga.com | ||
05.06. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | 12 | GlobeNewswire (USA) | ||
21.05. | Is Madrigal Pharmaceuticals Stock a Buy? | 13 | The Motley Fool | ||
08.05. | Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2024 Earnings Call Transcript | 16 | Insider Monkey | ||
07.05. | Madrigal Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary | 9 | Reuters | ||
07.05. | MADRIGAL PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | 6 | SEC Filings | ||
07.05. | MADRIGAL PHARMACEUTICALS, INC. - 8-K, Current Report | 8 | SEC Filings | ||
24.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Statement on the Passing of Dr. Stephen Harrison | 25 | GlobeNewswire (USA) | ||
16.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 194 | GlobeNewswire (Europe) | CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH)... ► Artikel lesen | |
05.04. | Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics | 37 | The Motley Fool | ||
03.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 88 | GlobeNewswire (Europe) | CONSHOHOCKEN, Pa., April 03, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis... ► Artikel lesen | |
02.04. | MADRIGAL PHARMACEUTICALS, INC. - 8-K, Current Report | 8 | SEC Filings | ||
29.03. | Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals | 34 | The Motley Fool | ||
26.03. | Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock | 24 | The Motley Fool | ||
25.03. | Baker Bros. Advisors LP acquires Madrigal Pharmaceuticals warrants worth $105 | 13 | Investing.com |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 815 |
RHEINMETALL | 489 |
TUI | 479 |
GAMESTOP | 457 |
EVOTEC | 364 |
DEUTSCHE LUFTHANSA | 361 |
NEL | 338 |
BAYER | 293 |
SNOWFLAKE | 293 |
TESLA | 277 |
BYD | 261 |
BASF | 208 |
VOLKSWAGEN | 198 |
DEUTSCHE TELEKOM | 185 |
PORSCHE SE | 183 |
APPLE | 180 |
MERCEDES-BENZ | 162 |
THYSSENKRUPP | 159 |
ALLIANZ | 151 |
DEUTSCHE BANK | 141 |
COMMERZBANK | 132 |
BROADCOM | 131 |
PLUG POWER | 131 |
MICROSOFT | 125 |
RWE | 124 |